Tackling Health Equity in Organ Transplantation
Merge Ahead: The New OPO Landscape & Ways Your OPO Can Prepare
AlloSeq HCT – The Latest Innovation in NGS-based Chimerism Testing
Score 6 Advanced Options and Troubleshooting Tips – Fast Results with Automated Analysis
Transplant Quality Outcomes – Part 2: Leveraging New & Existing Tools to Manage Your Quality Outcomes:…
Managing Your Outcomes in a World of Imperfect Organs and Higher Risk Recipients
Optimizing For The Long-Term Success Of Transplant Patients
Making Waitlist Management More Efficient Part 2
Improving your CareDx Surveillance Testing Workflows
Making Waitlist Management More Efficient – Part 1
Surviving and Thriving in the New Organ Allocation Systems – Part 2
Improving your CareDx Surveillance Testing Workflows
Surviving and Thriving in the New Organ Allocation Systems – Part 1
Role of Inflammation and Injury Post Heart Transplantation
ESOT 2021 – Symposium – Changing the Transplant Care Paradigm Advanced Strategies for Allograft…
AlloSeq cfDNA Webinar 2021, English + Portuguese–Organ Transplant Surveillance with AlloSeq cfDNA
2021 ESOT Webinar
ADN libre de células derivado de donante (dd-cfDNA): Vigilancia personalizada no invasiva en postrasplante
CareDx 6/7 ATC Symposium: Advancing Care in Kidney Transplantation – Groundbreaking Findings from ADMIRAL…
CareDx 6/6 ATC Symposium: AlloSure- dd-cfDNA Utility Beyond Kidney Transplantation
COVID-19 Vaccines and the Latest Data on Immune Response in Transplant Patients
HeartCare: The Utility of Multi-Modality in Transplant Patient Care
AlloSure Lung: Donor-Derived Cell Free DNA as an Innovative Biomarker for Lung Transplant Patients
Decreasing Transplant Wait Times by Increasing Living Donation